Chromatin Immunoprecipitation Sequencing (ChIP-Seq) Market By Product Type (Kits and Reagents, Antibodies, Instruments, Software and Services); By Application (Cancer Epigenetics, Developmental Biology, Neurobiology, Stem Cell Research, Immunology); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Hospitals & Clinical Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatin Immunoprecipitation Sequencing ( ChIP-Seq ) Market will expand at a robust CAGR of 8.6%, estimated at ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Frozen Tissue Samples Market By Sample Type (Human Tissue, Animal Tissue); By Application (Cancer Research, Genomic Studies, Drug Discovery, Transplant Diagnostics); By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CROs, Hospitals & Pathology Labs); By Storage Method (Snap-Frozen Tissues, Cryopreserved Tissues); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Frozen Tissue Samples Market is projected to expand steadily, growing at an CAGR of 6.8% between 2024 and 2030. The market was valued at USD 5.6 billion in 2024 and is on ... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

IVF Culture Media Market By Product Type (Embryo Culture Media, Sperm Preparation Media, Oocyte Handling Media, Cryopreservation Media, Others); By Application (IVF, ICSI, Other ART); By End User (Fertility Clinics, Academic and Research Centers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global IVF Culture Media Market is set to achieve a CAGR of 9.1% , with a value of $493 million in 2024 and projected to reach $882 mill... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

GMP Consumables Market By Product Type (Single-Use Bags & Containers, Filtration & Membranes, Tubing/Connectors/Fittings, Other Consumables); By Application (Biopharmaceutical Manufacturing, Sterile Pharmaceutical Production, Research & Development, Other Applications); By End User (CMOs, Large Pharmaceutical Companies, Biotech Startups, R&D Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global GMP Consumables Market is expected to witness a steady CAGR of 8.1%, valued at an estimated USD 7.5 billion in 2024 and projected to reach USD 11.... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Bioactive Protein and Peptide Market By Type (Bioactive Proteins, Bioactive Peptides); By Source (Animal-Based, Plant-Based, Fermentation/Synthetic); By Application (Functional Foods & Beverages, Clinical Nutrition, Pharmaceuticals, Cosmeceuticals, Animal Nutrition); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bioactive Protein And Peptide Market is expected to grow at a CAGR of 6.8%, reaching an estimated value of USD 5.7 billion in 2030, up fr... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Expression Vectors Market By Vector Type (Viral Vectors, Non-Viral Vectors); By Application (Therapeutics, Research & Development, Industrial Biotechnology, Agricultural Biotechnology); By End User (Biopharmaceutical Companies, Academic & Research Institutes, CROs, Industrial Biotechnology Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Expression Vectors Market is estimated to witness a robust CAGR of 9.5%, valued at around USD 4.8 billion in 2024, expected to appreciate and reach nearly... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Cell Permeabilization Market By Product Type (Chemical-Based Agents, Physical Permeabilization Tools, Enzyme-Based Solutions); By Application (Intracellular Protein Detection, Gene Transfection, Drug Discovery, Microbial Cell Studies); By End User (Academic & Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Permeabilization Market will experience a steady CAGR of 6.8%, valued at USD 768 million in 2024, and expected to cross USD 1.14 billion by 2030, acc... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Luciferase Assay Market By Assay Type (Single Luciferase Assay, Dual Luciferase Assay, Multiplex Luciferase Assay); By Application (Drug Discovery & Development, Gene Expression Analysis, Cancer Research, Virology & Vaccines); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Luciferase Assay Market is projected to grow at a CAGR of 6.9%, reaching an estimated USD 4.7 billion by 2030, up from USD 2.9 billion in 2024, according ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Immunogenetics Market By Product Type (Diagnostic Assays, Reagents & Consumables, Instruments & Platforms); By Application (Transplantation Genotyping, Autoimmune Diagnostics, Pharmacogenomics & Immunotherapy, Infectious Disease Susceptibility); By Technology (PCR, NGS, Microarray); By End User (Hospitals & Transplant Centers, Clinical Reference Labs, Academic & Research Institutes, Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immunogenetics Market is projected to grow at a robust CAGR of 8.9%, climbing from an estimated USD 5.8 billion in 2024 to USD 10.4 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Biological Imaging Reagents Market By Product Type (Fluorescent Dyes & Probes, Enzymes & Substrates, Antibodies & Proteins, Kits & Consumables); By Application (Cellular Imaging, Molecular Imaging, Diagnostics, Drug Discovery & Development); By End User (Research Laboratories, Biopharmaceutical Companies, Hospitals & Clinical Laboratories, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biological Imaging Reagents Market is poised to grow at a CAGR of 6.8%, valued at USD 5.2 billion in 2024, and projected to reach USD 8.1 billion ... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Chromatography Reagents Market By Type (Solvents, Buffers, Derivatization Reagents, Ion-Pair Reagents, Other Functional Reagents); By Technique (Liquid Chromatography, Gas Chromatography, Thin Layer Chromatography, Others); By End User (Pharmaceutical & Biotechnology, Environmental Testing, Food & Beverage, Academic & Research Labs, CROs & CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatography Reagents Market is projected to register a steady CAGR of 6.4% between 2024 and 2030. Valued at USD 7.9 billion in 2024, t... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Genome Perturbation Tools Market By Tool Type (CRISPR Systems, RNAi, Transposons, Antisense Oligonucleotides, Morpholinos); By Application (Drug Discovery, Functional Genomics, Disease Modeling, Synthetic Biology); By Delivery Method (Viral Vectors, Lipid Nanoparticles, Electroporation/Nucleofection); By End User (Academic Institutions, Biotech & Pharma, CROs, Synthetic Biology Startups); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Genome Perturbation Tools Market is projected to expand at a CAGR of 9.8%, rising from an estimated USD 3.7 billion in 2024 to USD 6.6 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Agricultural Biotechnology Market By Product Type (Transgenic Seeds, Gene-Edited Seeds, Biopesticides & Biofertilizers, Synthetic Biology Inputs); By Technology (Genetic Engineering, Genome Editing, RNAi, Molecular Diagnostics, Tissue Culture); By Application (Crop Production, Soil & Plant Health, Animal Feed, Industrial Agriculture); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Agricultural Biotechnology Market is poised to grow at a strong CAGR of 9.6%, reaching a valuation of around USD 78.4 billion in 2024, an... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Transcriptomics Market By Technology (RNA Sequencing, Microarrays, qPCR, Spatial Transcriptomics, Single-cell RNA-seq); By Application (Drug Discovery, Clinical Diagnostics, Toxicogenomics, Academic Research); By End User (Pharmaceutical Companies, Academic Institutions, Clinical Laboratories, CROs, Startups); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transcriptomics Market is projected to expand at a CAGR of 11.6%, reaching approximately USD 9.8 billion in 2024 and estimated to hit Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Skin Microbiome Market By Product Type (Probiotic Skincare, Prebiotic Skincare, Postbiotic Formulations, Microbiome Therapeutics); By Application (Cosmetic Skincare, Medical Dermatology, Personal Hygiene); By End User (Consumers, Dermatology Clinics, Pharmaceutical & Biotech Companies, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Microbiome Market will witness a promising CAGR of 14.6%, valued at USD 1.98 billion in 2024, and projected to reach USD 4.52 billion by 2030, accord... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Xenotransplantation Market By Product Type (Solid Organs [Kidney, Heart, Liver], Cellular & Tissue Transplants); By Application (End-Stage Organ Failure, Regenerative/Immunotherapy Applications); By End User (Hospitals & Transplant Centers, Research Institutes, Cellular Therapy Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Xenotransplantation Market is poised to witness a compelling CAGR of 13.5%, valued at USD 1.2 billion in 2024, and projected to reach USD 2.7 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Optogenetics Market By Product Type (Channelrhodopsins, Halorhodopsins, Archaerhodopsins, Red-Shifted Opsins); By Light Source (Laser Systems, LED Systems, Fiber Optics, Wireless Optical Devices); By Application (Neuroscience, Retinal Disorders, Cardiology, Psychiatric and Behavioral Research); By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, Clinical and Translational Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Optogenetics Market will witness steady growth over the coming years, expanding at an estimated CAGR of 14.8% , valued at around USD 780 million in 2024 and projected to s... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Lysosomal Enzymes Market By Type (Acid Hydrolases, Proteases, Glycosidases, Lipases); By Disease Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidosis [MPS I, II, VI], Others); By Source (Human Recombinant Systems, Animal Cell Culture, Microbial Expression Systems); By End User (Pharmaceutical & Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals & Clinical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lysosomal Enzymes Market is projected to register a steady CAGR of 6.5% , valued at around USD 7.8 billion in 2024 and expected to reach nearly USD 12.1 billion by... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Polyclonal Antibodies Market By Source (Rabbit, Goat, Sheep, Others); By Application (Research, Diagnostics, Therapeutics, Veterinary); By End User (Academic & Research Institutes, Pharmaceutical & Biotech Companies, Diagnostics Manufacturers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Polyclonal Antibodies Market is projected to expand steadily at a CAGR of 5.9%, reaching a market value of USD 2.34 billion in 2024 and forecasted to grow... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Reporter Tags Market By Tag Type (Fluorescent Tags, Enzymatic Tags, Epitope Tags, Radioactive & Chemiluminescent Tags); By Application (Gene Expression Analysis, Drug Screening, Protein Localization, Synthetic Biology, Biomarker Discovery); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Diagnostic Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Reporter Tags Market is projected to reach $1.46 billion by 2030, up from an estimated $880 million in 2024, growing at a CAGR of 8.7% du... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Archaeosomes Market By Product Type (Synthetic Archaeosomes, Natural Archaeosomes); By Application (Vaccine Delivery, Cancer Immunotherapy, Gene Therapy, Oral Drug Delivery, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CDMOs, Government & Nonprofit Research Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Archaeosomes Market is poised for steady growth, with an estimated value of USD 143.7 million in 2024, projected to reach USD 271.2 million by 203... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Blocking Buffers Market By Type (Protein-Based, Synthetic, Serum-Based/Hybrid); By Application (Western Blotting, ELISA, Immunohistochemistry, Flow Cytometry); By End User (Academic & Research Institutes, Biotech & Pharma Companies, CROs, Clinical Diagnostics Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blocking Buffers Market will grow at a steady CAGR of 6.5%, valued at USD 1.2 billion in 2024 and projected to reach USD 1.77 billion by 2030, according t... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Desalting and Buffer Exchange Market By Product Type (Columns, Membrane Filters, Centrifugal Devices, Pre-packed Systems); By Technique (Gel Filtration, Ultrafiltration, Dialysis); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutes, Diagnostic Manufacturers); By Application (Protein Purification, Antibody Formulation, Viral Vector Preparation, Diagnostic Assay Development); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Desalting And Buffer Exchange Market is poised for steady expansion through 2030, registering an estimated CAGR of 6.8%. The market is projected to reach ... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Epitope Tags Market By Tag Type (His-tag, FLAG-tag, HA-tag, c-Myc, V5, Custom Tags); By Application (Protein Purification, Detection & Localization, Protein-Protein Interaction Studies, Therapeutic Development, Vaccine R&D); By End User (Academic & Research Institutes, Biopharmaceutical Companies, CROs/CDMOs, Diagnostic Developers, Synthetic Biology Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Epitope Tags Market is estimated to reach a value of USD 408.6 million in 2024, and is projected to grow steadily to about USD 692.1 million by 2030, marking a CAG... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

MicroRNA Reverse Transcription Market By Product Type (Reverse Transcription Kits, Reagents, Instruments, Consumables); By Application (Cancer Research, Neurological Disorders, Cardiovascular Disorders, Others); By End User (Academic and Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, CROs, Government and Non-Profit Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global MicroRNA Reverse Transcription Market is expected to witness significant growth over the forecast period, projected to reach a market value of approximately USD 2.... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Chromatography Food Testing Market By Type (Gas Chromatography, Liquid Chromatography, HPLC, LC-MS, GC-MS); By Application (Pesticide Residue Testing, Toxin Screening, Additive & Preservative Testing, Allergen Detection, Nutritional Label Validation); By End User (Food & Beverage Manufacturers, Independent Testing Laboratories, Government & Regulatory Agencies, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatography Food Testing Market will witness a robust CAGR of 6.5%, valued at USD 8.1 billion in 2024, expected to appreciate and reach USD 11.9 billion by 2030... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Digital Genome Market By Component (Sequencing Platforms, Software & Services, Storage & Cloud Infrastructure, Sample Preparation); By Application (Precision Medicine, Drug Discovery, Diagnostics, Agricultural Genomics, Forensics); By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotech Companies, Public Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Digital Genome Market will witness a robust CAGR of 10.8% , valued at USD 29.4 billion in 2024 , and projected to reach USD 60.5 billion by 2030 , accordi... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

GMP Cytokines Market By Cytokine Type (Interleukins, Interferons, Growth Factors, Tumor Necrosis Factors, Chemokines); By Application (Cell & Gene Therapy Manufacturing, Vaccine Production, Bioprocess Development, Clinical-Grade Ex Vivo Expansion, Direct Therapeutic Use); By End User (Biopharma Companies, CDMOs, Academic & Clinical Research Centers, Hospitals, Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global GMP Cytokines Market is on track for steady growth through 2030, with a projected CAGR of around 9.1%, reaching an estimated value of $565 million... Read More

Published Date: JAN-2026 | No Of Pages:174 | $ 4485

Custom Antibody Market By Antibody Type (Monoclonal, Polyclonal, Recombinant, Others); By Service (Development, Production & Purification, Characterization & Validation); By Application (Drug Discovery & Development, Diagnostics, Proteomics & Genomics Research, Therapeutics); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Hospitals & Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Custom Antibody Market will expand at a steady pace between 2024 and 2030, growing at an estimated CAGR of 10.2 %. The market is valued at USDRead More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Biological Buffers Market By Product Type (Phosphate Buffers, Tris Buffers, HEPES & Zwitterionic Buffers, Good’s Buffers); By Application (Life Sciences Research, Biopharmaceutical Production, Clinical Diagnostics, Academic & Government Research); By End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Academic & Research Institutes, CROs & CDMOs, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biological Buffers Market is projected to expand steadily at a CAGR of 6.8%, reaching nearly USD 1.45 billion in 2024 and expected to touch USD 2.15 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Cell Line Development Serum Market By Product Type (Fetal Bovine Serum, Human Serum, Animal-Free Alternatives); By Application (Biopharmaceutical Production, Stem Cell Research, Vaccine Development, Gene Therapy); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs/CDMOs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Line Development Serum Market will witness a robust CAGR of 8.1%, valued at USD 1.9 billion in 2024, expected to appreciate and reach nearly USD 3.0 billion b... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Vectorized Antibodies for In Vivo Expression Market By Delivery Vector (mRNA-based Vectors, AAV & Viral Vectors, DNA Plasmids & Synthetic Systems); By Therapeutic Application (Infectious Diseases, Oncology, Rare Genetic Disorders, Autoimmune Diseases); By End User (Biopharma Companies, Academic Research Centers, Public Health Agencies, Military Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vectorized Antibodies For In Vivo Expression Market is expected to grow at a robust CAGR of 11.7%, with a valuation of USD 3.2 billion in 2024, projected to reach ... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Viral Clearance Market By Product Type (Viral Filtration Systems, Chromatography-based Viral Clearance, Inactivation Agents); By Application (Gene Therapy, Biologics, Vaccines, Blood and Plasma Products); By End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Research and Academic Institutions, Blood and Plasma Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viral Clearance Market is poised for strong growth, registering a compound annual growth rate (CAGR) of approximately 8.5%. Valued at USD 1.8 billion in 2024, the market i... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Nanobodies Market By Application (Therapeutics, Diagnostics, Research Tools); By Therapeutic Area (Oncology, Autoimmune Diseases, Neurology, Infectious Diseases); By End User (Biopharma Companies, Academic Research Institutes, Diagnostic Labs, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nanobodies Market will witness a strong CAGR of 13.8%, valued at USD 1.4 billion in 2024 and expected to reach nearly USD 3.1 billion by 2030 , according ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Oligonucleotide Therapeutics Market By Drug Type (Antisense Oligonucleotides, Small Interfering RNAs, Aptamers, Others); By Application (Rare Genetic Disorders, Oncology, Metabolic/Liver Diseases, Infectious Diseases, Ophthalmology); By Route of Administration (Subcutaneous, Intrathecal, Intravenous, Others); By End User (Academic Hospitals, Specialty Clinics, Outpatient Centers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oligonucleotide Therapeutics Market is expected to witness a strong CAGR of 14.6%, valued at USD 8.1 billion in 2024 and projected to surpass USD 18.4 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Adipose-derived Stem Cell Market By Cell Type (Autologous, Allogenic); By Application (Regenerative Medicine, Aesthetic Medicine, Wound Healing & Tissue Repair, Drug Discovery & Research); By End User (Hospitals & Specialty Clinics, Cosmetic & Aesthetic Clinics, Research Institutions, Biotech & Cell Therapy Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adipose-Derived Stem Cell Market will witness a robust CAGR of 9.6%, valued at USD 1.6 billion in 2024 and expected to reach USD 2.8 billion by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Plant-based Vaccines Market By Vaccine Type (Prophylactic Vaccines, Therapeutic Vaccines); By Target Indication (Influenza, COVID-19, HPV, Zika Virus, Others); By Plant System (Tobacco, Maize, Potato, Tomato, Lettuce); By End User (Public Health Agencies, Hospitals & Clinics, Academic & Research Institutions, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plant-Based Vaccines Market is projected to expand at a robust pace between 2024 and 2030, with the market estimated at around USD 1.4 billion in 2024 and forecasted to re... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Gene Therapy in Ophthalmology Market By Therapy Type (Gene Augmentation, Gene Editing, RNA-based Therapy); By Disease Indication (Leber Congenital Amaurosis, Retinitis Pigmentosa, Stargardt Disease, Choroideremia, X-linked Retinoschisis, Wet AMD, Diabetic Macular Edema); By Delivery Method (Subretinal, Suprachoroidal, Intravitreal); By End User (Academic Medical Centers, Specialty Retina Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gene Therapy In Ophthalmology Market will witness a robust CAGR of 26.5% , valued at USD 1.42 billion in 2024 , and expe... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Continuous Bioprocessing Market By Product Type (Upstream Bioreactors, Continuous Chromatography, TFF Systems, PAT, Single-Use Systems, Automation Software); By Application (Clinical Production, Commercial Manufacturing, R&D, Process Development); By End User (Pharmaceutical Companies, Biotech Startups, CDMOs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Continuous Bioprocessing Market will witness a robust CAGR of 15.1%, valued at USD 4.3 billion in 2024, expected to appreciate and reach USD 10.2 billion by 2030,<... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Nucleic Acid Therapeutics Market By Therapy Type (Antisense Oligonucleotides, RNA Interference, mRNA Therapeutics, Aptamers, Others); By Application (Genetic Disorders, Oncology, Infectious Diseases, Neurological Disorders, Others); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nucleic Acid Therapeutics Market will witness a robust CAGR of 16.3%, valued at USD 6.8 billion in 2024 and expected to appreciate and reach USD 16.4 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Nano Biotechnology Market By Product Type (Nanoparticles and Nano-carriers, Nano-biosensors, Nano-imaging agents, Nanostructured scaffolds, Nano-based reagents); By Application (Drug Delivery, Diagnostics, Regenerative Medicine, Therapeutics, Agriculture, Food Safety); By End User (Hospitals and Clinics, Research Institutes and Universities, Biotechnology and Pharmaceutical Companies, Diagnostic Labs, Agriculture and Food Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nano Biotechnology Market is projected to grow at an CAGR of 12.3% from 2024 to 2030, with an estimated value of $48.7 billion in 2024 and a forecasted value of $9... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Nano Bioreactor Market By Product Type (Microfluidic Nano Bioreactors, Stirred Tank Nano Bioreactors, Perfusion-Based Nano Bioreactors, Batch and Fed-Batch Nano Bioreactors); By Application (Biopharmaceutical R&D, Cell Therapy, Synthetic Biology, Single-Cell Analysis, Academic Research); By End User (Biotech and Pharma Companies, CROs, Academic and Government Institutes, Diagnostic Startups); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nano Bioreactor Market is on track to grow at a CAGR of 13.9%, valued at approximately USD 620.4 million in 2024 and projected to reach nearly USD... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Virtual 3D Nanorobots Market By Application (Medical Research & Simulation, Nano-Drug Delivery, Nano-Surgical Training, Non-Medical Industrial Applications); By Component (Simulation Software Platforms, Visualization Interfaces, Predictive Modeling Tools); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Hospitals & Training Centers, Defense & Aerospace Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Virtual 3D Nanorobots Market is projected to expand at a rapid pace, moving from an estimated USD 1.8 billion in 2024 to approximately Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Nanoencapsulation Market By Material Type (Polymeric, Lipid-Based, Protein-Based); By Application (Pharmaceuticals, Functional Foods & Nutraceuticals, Cosmetics & Personal Care, Agrochemicals, Others); By End User (Pharmaceutical & Biotech Companies, Food & Beverage Manufacturers, Cosmetic Brands, Agrochemical Producers, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nanoencapsulation Market is set to expand at a CAGR of 11.6%, reaching a valuation of USD 7.9 billion in 2024, and projected to cross USD 15.3 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Muscarinic Acetylcholine Receptor Market By Product Type (Agonists, Antagonists, Allosteric Modulators); By Application (Neurology, Psychiatry, Respiratory, Ophthalmology, Cardiology); By Route of Administration (Oral, Inhalation, Topical/Ocular, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes, Community Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Muscarinic Acetylcholine Receptor (Machr) Market is set to grow at a CAGR of 6.8% , valued at USD 4.7 billion in 2024 and projected to re... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Artificial Womb Facility Market By Technology Type (Ex Vivo Biobag Systems, Integrated Artificial Placenta, Closed-Loop Monitoring Platforms, Others); By Application (Preterm Birth Support, Neonatal Disease Research, Fertility & Reproductive Medicine, Organ Maturation); By End User (Specialized Neonatal Hospitals, Research Institutes, Biotechnology Firms, IVF Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artificial Womb Facility Market will witness a remarkable CAGR of 24.6%, valued at USD 1.3 billion in 2024, and projected to grow to USD 4.9 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Antimicrobial Peptides Market By Product Type (Natural Peptides, Synthetic Peptides, Recombinant Peptides); By Application (Infectious Diseases, Dermatology, Oncology, Wound Healing, Others); By End User (Hospitals, Research Institutes, Pharmaceutical & Biotech Companies, Veterinary Clinics, Agricultural Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimicrobial Peptides Market is projected to grow at a CAGR of 8.1%, valued at around USD 1.65 billion in 2024 and expected to reach USD 2.8 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Lipid-Nanoparticle Based Genomic Medicines Market By Product Type (mRNA-Based Systems, siRNA-Based Systems, CRISPR and Gene-Editing Systems, DNA Plasmid-Based Systems); By Application (Oncology, Rare Genetic Disorders, Infectious Diseases, Regenerative Medicine); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic & Research Institutes, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lipid-Nanoparticle Based Genomic Medicines Market is projected to grow at a CAGR of 11.8%, valued at USD 6.9 billion in 2024 and expected to reach nearly USD 13.6 ... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Gut Microbiome Market By Product Type (Probiotics & Prebiotics, Microbiome Therapeutics, Diagnostics & Testing Kits); By Application (Digestive Health, Metabolic Disorders, Immunity & Inflammation, Mental Health, Oncology Support); By End User (Consumers, Hospitals & Clinics, Diagnostic Labs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gut Microbiome Market is poised to grow at a robust pace, reaching a value of $2.41 billion in 2024, and projected to cross $6.19 billion by 2030, expanding at a C... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Targeted Sequencing and Resequencing Market By Technology (Amplicon-Based, Hybridization-Based, CRISPR-Based); By Workflow Step (Sample Preparation, Library Preparation, Target Enrichment, Sequencing, Data Analysis); By Application (Oncology, Rare Disease, Pharmacogenomics, Reproductive Health); By End User (Clinical Laboratories, Academic & Research Institutions, Hospitals, Biopharma & CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Sequencing And Resequencing Market will witness a steady CAGR of 10.6%, valued at around USD 6.1 billion in 2024, expected to gr... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

CD Antigen Cancer Therapy Market By Antigen Target (CD19, CD20, CD22, CD33, CD47, CD123, Others); By Therapy Type (Monoclonal Antibodies, CAR-T Therapies, Bispecific Antibodies, Antibody-Drug Conjugates); By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Academic Medical Centers, Specialty Cancer Hospitals, General Hospitals, Cell Therapy Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global CD Antigen Cancer Therapy Market will witness a strong CAGR of 16.2%, valued at USD 3.9 billion in 2024 and projected to reach USD 9.6 billion by ... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Immortalized Cell Line Market By Product Type (Human-Derived Cell Lines, Animal-Derived Cell Lines); By Application (Oncology, Virology, Immunology, Genetic Disorders, Stem Cell Research); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immortalized Cell Line Market is projected to grow from USD 5.6 billion in 2024 to USD 9.4 billion by 2030 at a 9.1% CAGR, driven by rising demand for hum... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Biopharmaceutical Fermentation Market By Product Type (Microbial Fermentation, Mammalian Fermentation); By Application (Vaccines, Monoclonal Antibodies, Recombinant Proteins, Insulin and Hormones, Gene Therapy Vectors); By End User (Biopharmaceutical Companies, Contract Development & Manufacturing Organizations, Academic & Research Institutes, Government & Nonprofit Entities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biopharmaceutical Fermentation Market is projected to grow at a strong 8.1% CAGR, rising from USD 29.7 billion in 2024 to USD 47.5 billion by 2030, driven... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Single Cell Multiomics Market By Technology Platform (Genomics, Transcriptomics, Epigenomics, Proteomics, Integrated Multiomics); By Application (Basic Research, Drug Discovery & Development, Clinical Diagnostics); By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Clinical Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Single Cell Multiomics Market is projected to grow at a robust 14.5% CAGR, rising from USD 3.8 billion in 2024 to nearly USD 9.0 billion by 2030, driven b... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Cardiac Tissue Engineering Market By Product Type (Cardiac Patches, Injectable Hydrogels, Bioprinted Tissues, Others); By Application (Ischemic Heart Disease, Heart Failure, Congenital Defects, Others); By End User (Academic and Research Institutes, Specialized Cardiac Centers, General Hospitals, Pharmaceutical and Biotech Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Tissue Engineering Market is projected to grow at a strong 11.8% CAGR, rising from USD 1.3 billion in 2024 to USD 2.8 billion by 2030, driven by a... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Mammalian Polyclonal IgG Antibody Market By Source (Rabbit, Goat, Horse, Sheep); By Application (Diagnostics, Research, Drug Discovery); By End User (Academic and Research Institutes, Biopharma Companies, Diagnostic Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mammalian Polyclonal IgG Antibody Market is projected to grow at a 8.1% CAGR, rising from USD 1.8 billion in 2024 to USD 2.9 billion by 2030, driven by ex... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

RNA Polymerase Market By Product Type (Bacterial RNA Polymerase, Phage RNA Polymerase, Eukaryotic RNA Polymerase); By Application (mRNA Therapeutics, Vaccine Manufacturing, Molecular Diagnostics, Synthetic Biology, Research); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RNA Polymerase Market is projected to grow at a steady 6.8% CAGR, rising from $820 million in 2024 to nearly $1.22 billion by 2030, driven by mRNA therape... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Stem Cell Exosome Therapeutics Market By Product Type (Natural Exosomes, Engineered Exosomes); By Application (Oncology, Neurology, Wound Healing & Dermatology, Inflammatory & Autoimmune Disorders); By Route of Administration (Injectable, Topical, Intranasal, Oral); By End User (Academic & Research Institutes, Biotech & Pharma Companies, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stem Cell Exosome Therapeutics Market is poised for accelerated growth, witnessing a projected CAGR of 27.5%, valued at USD 0.82 billion in 2024 and expec... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Molecular Glue Degrader Market By Target Protein (IKZF1/3, GSPT1, BCL6, STAT3, BRD9, Others); By Indication (Oncology, Neurology, Immunology, Others); By End User (Biopharma Companies, Academic Research Centers, CROs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Molecular Glue Degrader Market is expected to witness transformative growth at a CAGR of 36.8%, rising from USD 413.0 million in 2024 to USD 2.75 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Gene and Cell Therapies Targeting CNS Disorders Market By Therapy Type (Gene Therapy, Cell Therapy, Gene-Modified Cell Therapy); By Indication (Parkinson’s Disease, ALS, SMA, Huntington’s Disease, Alzheimer’s Disease, Rare Pediatric CNS Disorders); By Delivery Method (Intrathecal, Intravenous, Intraparenchymal, Intranasal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene and Cell Therapies Targeting CNS Disorders Market is set to grow at a compelling CAGR of 18.4% , starting from an e... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Cereblon E3 Ligase Modulators Market By Product Type (First-Generation IMiDs, Next-Generation Protein Degraders); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By End User (Hospital Oncology Departments, Specialty Cancer Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cereblon E3 Ligase Modulators Market is projected to expand at a strong CAGR of 12.5%, rising from USD 2.1 billion in 2024 to USD 4.1 billion by 2030, fue... Read More

Published Date: DEC-2025 | No Of Pages:183 | $ 4485

mRNA Cancer Vaccines Market By Cancer Type (Melanoma, Lung, Pancreatic, Colorectal, Breast, Prostate); By Vaccine Type (Personalized mRNA Vaccines, Off-the-Shelf Vaccines); By Delivery Mechanism (Lipid Nanoparticles, Polymer-Based Carriers, Exosomes); By End User (Academic & Research Institutes, Specialty Oncology Clinics, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Cancer Vaccines Market is set for transformative growth between 2024 and 2030, valued at USD 1.8 billion in 2024 and projected to reach nearly USD 7.3 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

TROP2 Antibody Market By Drug Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Breast Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma, Others); By End User (Academic & Research Hospitals, Oncology Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TROP2 Antibody Market will witness a robust CAGR of 20.6%, valued at USD 1.8 billion in 2024, expected to appreciate and reach US... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

CD19 Antibody Market By Antibody Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates); By Application (Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Autoimmune Disorders, Others); By End User (Hospitals, Specialty Cancer Centers, Community Hospitals & Clinics, Outpatient Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD19 Antibody Market is projected to grow at a robust 14.8% CAGR, expanding from USD 3.1 billion in 2024 to approximately USD 7.1 billion by 2030, driven ... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

CD276 Antibody Market By Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Oncology, Immuno-Oncology Research); By End User (Biopharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD276 Antibody Market is valued at USD 450 million in 2024 and is projected to reach USD 1.1 billion by 2030, expanding at a strong 15.8% CAGR, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Bicycle Toxin Conjugates Market By Product Type (Proprietary BTCs, Platform-Based BTCs, Next-Gen Conjugates); By Application (Oncology, Rare Diseases, Infectious Diseases); By End User (Academic Medical Centers, Cancer Institutes, Specialized Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bicycle Toxin Conjugates Market is projected to grow at a robust 8.9% CAGR, expanding from $2.1 billion in 2024 to $3.6 billion by 2030, driven by advance... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

CD137 Antibody Market By Type (Monoclonal Antibodies, Bispecific Antibodies, Fc-Engineered Variants); By Application (Solid Tumors, Hematologic Malignancies, Combination Immunotherapy); By Development Stage (Preclinical, Phase I, Phase II, Phase III); By End User (Academic Cancer Centers, Biopharma Companies, CROs, Specialty Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD137 Antibody Market is valued at USD 782 million in 2024 and is projected to reach USD 1.43 billion by 2030, expanding at a strong 10.6% CAGR, driven by... Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

CD3 Antibodies Market By Product Type (Monospecific CD3 Antibodies, Bispecific and Multispecific CD3 Antibodies); By Application (Oncology, Autoimmune Diseases, Transplantation, Others); By End User (Academic Hospitals, Specialty Clinics, Community Hospitals, CROs); By Route of Administration (Intravenous, Subcutaneous, Other Routes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD3 Antibodies Market is projected to grow from USD 2.7 billion in 2024 to nearly USD 5.0 billion by 2030, expanding at a strong 10.8% CAGR, driven by adv... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Multispecific Antibodies Market By Technology Type (Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Formats); By Therapeutic Application (Oncology, Autoimmune & Inflammatory Disorders, Infectious Diseases, Others); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Multispecific Antibodies Market is gaining momentum, with the sector projected to expand steadily between 2024 and 2030. Based on inferred estimates, the market is valued ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Aryl Hydrocarbon Receptor Market By Drug Type (AhR Agonists, AhR Antagonists, Natural Ligands, Synthetic Ligands); By Therapeutic Application (Oncology, Autoimmune Disorders, Gastrointestinal Disease, Neuroinflammation, Dermatology); By Mechanism of Action (Direct Modulators, Indirect Modulators); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Aryl Hydrocarbon Receptor (Ahr) Market is projected to grow at a steady CAGR of 6.1%, estimated to reach approximately USD 738.4 million by 2030Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Medical Biomimetics Market By Product Type (Biomimetic Materials, Biomimetic Devices, Biomimetic Drug Delivery Systems); By Application (Cardiovascular, Orthopedic & Musculoskeletal, Ophthalmology, Dental, Others); By End User (Hospitals & Surgical Centers, Specialty Clinics, Academic & Research Institutes, Pharmaceutical & Biotech Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medical Biomimetics Market to grow from $39.2 billion in 2024 to $71.4 billion by 2030 at a 10.3% CAGR, driven by bioinspired implants, regenerative mater... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Myc Proto Oncogene Protein Market By Product Type (Therapeutics, Diagnostics, Research Reagents); By Application (Oncology Therapeutics, Biomarker-Based Diagnostics, Research & Development); By End User (Hospitals & Cancer Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myc Proto Oncogene Protein Market is anticipated to witness a robust CAGR of 8.5%, valued at around USD 4.2 billion in 2024, and is expected to reach USD 7.0 billi... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Ubiquitin Enzymes Market By Enzyme Class (E1 Activating Enzymes, E2 Conjugating Enzymes, E3 Ligases, Deubiquitinases); By Application (Drug Discovery & Development, Diagnostics & Biomarker Research, Basic Research, Therapeutics); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, CROs, Diagnostics & Clinical Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ubiquitin Enzymes Market is projected to expand steadily between 2024 and 2030, with an estimated value of USD 1.2 billion in 2024 and likely to reach USD 2.1 bill... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Live Cell Encapsulation Market By Polymer Type (Alginate-based, PEG-based, Synthetic, Natural Blends); By Cell Type (Islet Cells, Stem Cells, Immune Cells, Hepatocytes, Neural Cells); By Application (Therapeutics, Research Models, Biosensor Platforms); By End User (Academic & Research Institutes, Biotech Companies, Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Live Cell Encapsulation Market is projected to grow at a steady 7.9% CAGR, rising from USD 320.0 million in 2024 to approximately USD 505.0 million by 2030Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Buffer Preparation Market By Product Type (Automated Buffer Systems, Single-Use Buffer Systems, Manual & Semi-Automated Systems); By Application (Upstream Processing, Downstream Processing, Formulation & Fill-Finish); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Buffer Preparation Market is valued at USD 4.8 billion in 2024 and is projected to reach USD 7.6 billion by 2030, expanding at a 7.9% CAGR, driven by risi... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Next Generation Drug Conjugates Market By Product Type (Antibody-Drug Conjugates, Peptide-Drug Conjugates, Polymer-Drug Conjugates, Small Molecule-Drug Conjugates); By Payload Type (Cytotoxic Agents, Immune-Stimulatory Agents, RNA/siRNA Payloads, Antimicrobial Payloads); By Application (Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Conditions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Next Generation Drug Conjugates Market is projected to grow from USD 3.6 billion in 2024 to USD 6.1 billion by 2030 at a 9.1% CAGR, driven by innovation in antibody-drug conjugates, peptid... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Fc Fusion Protein Market By Therapeutic Area (Autoimmune Diseases, Oncology, Rare Diseases, Ophthalmology, Infectious Diseases); By Drug Type (Cytokine-Fc Fusions, Receptor-Fc Fusions, Enzyme-Fc Fusions, Hormone-Fc Fusions); By End User (Specialty Hospitals, Infusion Centers, Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fc Fusion Protein Market is expected to experience notable growth at a CAGR of 10.3%, increasing from USD 5.6 billion in 2024 to USD 10.1 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Gene Switch Market By Switch Mechanism (Small-Molecule Inducible, Optogenetic, RNA-Based, CRISPR- and Protein-Based); By Application (Cell & Gene Therapy Safety, Synthetic Biology & Biomanufacturing, Agriculture & Plant Engineering, Basic Research Tools); By End User (Biopharmaceutical Companies, Academic & Research Institutes, Agri-Biotech Firms, Industrial Biotech & Manufacturing Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene Switch Market is estimated to be valued at USD 1.9 billion in 2024 and is projected to reach USD 5.6 billion by 2030 , growing at a CAGR of 19.8% ove... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

cGAS STING Pathway Market By Product Type (Agonists, Antagonists, Modulators); By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Rare Genetic Disorders); By End User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global cGAS STING Pathway Market is projected to see robust expansion through the decade, with an estimated CAGR of 22% , valued at USD ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Immunocytokines Market By Product Type (Tumor-Targeted Immunocytokines, Anti-Inflammatory Immunocytokines, Next-Generation Modular Constructs); By Therapeutic Application (Oncology, Autoimmune & Inflammatory Disorders, Infectious Diseases); By Route of Administration (Intravenous, Subcutaneous, Targeted Delivery Platforms); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immunocytokines Market is projected to expand steadily between 2024 and 2030, with an inferred CAGR of 10.8% , reaching an estimated value of USD ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

RNA Extraction and RNA Purification Market By Product Type (RNA Extraction Kits, Reagents, Columns, Magnetic Beads, Instruments); By Technology (Silica Membrane-Based, Magnetic Bead-Based, Phenol-Chloroform); By End User (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RNA Extraction and RNA Purification Market is projected to grow at a robust CAGR of 7.8% , valued at Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Cold Plasma Market By Application (Wound Healing, Surface Sterilization, Food Safety, Cancer Therapy, Surface Activation); By Industry (Healthcare, Electronics, Food Processing, Textiles, Aerospace); By Device Type (Atmospheric Pressure, Low-Pressure Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Plasma Market will grow at a notable CAGR of 10.2%, expanding from $3.9 billion in 2024 to $7.1 billion by 2030, driven by plasma reactorsRead More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Research Antibodies and Reagents Market By Product Type (Primary Antibodies, Secondary Antibodies, ELISA Kits, Recombinant Proteins, Assay Kits, Custom Reagents); By Application (Research & Development, Diagnostics, Therapeutics, Personalized Medicine); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Clinical Diagnostics Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Research Antibodies and Reagents Market is anticipated to grow steadily at a CAGR of 8.3%, valued at USD 13.5 billion in 2024 and forecasted to reach USD 21.8 bill... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Viral Vector Purification Market By Vector Type (Adenoviral, Lentiviral, AAV, Others); By Purification Method (Chromatography, Filtration, Centrifugation, Others); By End User (Biopharmaceutical Companies, CDMOs, Academic/Research Labs); By Application (Gene Therapy Manufacturing, Cell Therapy, Vaccine Production, Research); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Viral Vector Purification Market is set to expand considerably at a CAGR of 13.1%, valued at USD 1.1 billion in 2024 and forecasted to hit USD 2.3 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Microbial Fermentation CMO Market By Strain Type (Bacteria, Yeast, Fungi); By Service Type (Process Development, GMP Manufacturing, Analytical & Regulatory, Scale-Up & Tech Transfer); By Application (Biopharmaceuticals, Industrial Enzymes, Food & Ingredients, Cosmetics & Specialty Chemicals); By End User (Biopharma Companies, Industrial Firms, Synbio Startups, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microbial Fermentation CMO Market is projected to grow at a robust CAGR of 9.3% , reaching USD 5.2 billion in 2024 , and expected to exceed USD 8.... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Plant-Based Protein Expression Market By Expression System (Transient Expression, Stable Expression); By Application (Therapeutic Proteins, Vaccines, Industrial Enzymes, Nutraceuticals); By End User (Biopharmaceutical Companies, CDMOs, Academic Institutions, Agro-Biotech Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plant-Based Protein Expression Market will witness a strong CAGR of 9.8% from 2024 to 2030, valued at USD 1.6 billion in 2024 and projected to reach nearl... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Transfer Membrane Market By Product Type (Western Blot, Southern/Northern Blot, Dot/Slot Blot); By Material (Nitrocellulose, PVDF, Nylon); By Application (Protein Analysis, Nucleic Acid Detection, Diagnostics, Food & Environmental Testing); By End User (Academic Institutes, Pharma & Biotech, Clinical Labs, Food & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transfer Membrane Market is projected to expand at a steady CAGR of 6.5%, valued at USD 1.1 billion in 2024 and expected to reach nearly USD 1.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:158 | $ 4485

DNA Vaccine Market By Type (Plasmid DNA Vaccines, Recombinant DNA Vaccines); By Application (Infectious Diseases, Oncology, Veterinary); By End User (Hospitals, Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Vaccine Market is projected to experience rapid expansion at a CAGR of 12.8%, growing from USD 4.3 billion in 2024 to USD 9.1 billion by 2030, driven ... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Automatic Aseptic Sampling Market By Product Type (Modular Sampling Systems, Single-Use Sampling Devices, Multi-Port Automated Stations); By Application (Biopharmaceuticals, Vaccines, Cell & Gene Therapy); By End User (Biopharma Manufacturers, CMOs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Automatic Aseptic Sampling Market is expected to grow at a CAGR of 10.3%, advancing from USD 850 million in 2024 to USD 1.7 billion by 2030, propelled by ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

mRNA Synthesis and Manufacturing Market By Workflow Stage (Upstream Template Synthesis, IVT Transcription, Downstream Purification & Capping, Formulation & Fill-Finish); By Application (Vaccines, Oncology, Gene Editing, Autoimmune & Rare Diseases); By End User (Biopharma Innovators, CDMOs, Academic Institutes, Government/Public Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Synthesis and Manufacturing Market is on track to expand at a CAGR of 11.8% , reaching approximately USD 14.6 billion by 2030 , up f... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Biopreservation Market By Product Type (Biopreservation Media, Equipment, LIMS, Accessories & Consumables); By Biospecimen Type (Stem Cells, Organs, DNA/RNA, Blood Samples, Human Tissues, Vaccines); By Application (Biobanking, Regenerative Medicine, Drug Discovery, Transplant Medicine); By End User (Pharmaceutical & Biotech Companies, Hospitals, Academic Institutes, Biobanks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biopreservation Market will expand from USD 5.8 billion in 2024 to nearly USD 9.7 billion by 2030, growing at a CAGR of 8.9% during the period 2024–... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

1 2 3 4